Variables | Total enrolled N | Completed the trial and received prophylaxis n (%) | p- value | Lost to follow up n (%) | p- value | Discontinued taking drug n (%) | p-value |
---|---|---|---|---|---|---|---|
Treatment Arm | Â | Â | 0.08 | Â | 0.90 | Â | 0.01* |
 Al | 738 | 607 (82) |  | 79 (11) |  | 48 (7) |  |
 MV | 742 | 635 (86) |  | 78 (11) |  | 25 (3) |  |
Sex | Â | Â | 0.56 | Â | 0.002* | Â | 0.005* |
 Female | 345 | 286 (83) |  | 20 (6) |  | 31 (9) |  |
 Male | 1135 | 956 (84) |  | 137 (12) |  | 42 (4) |  |
Age groups (years) | Â | Â | 0.05 | Â | 0.003* | Â | 0.61 |
 Age ≤ 30 | 794 | 651 (82) |  | 102 (13) |  | 35 (4) |  |
 Age > 30 and  ≤ 40 | 359 | 304 (85) |  | 33 (9) |  | 20 (6) |  |
 Age > 40 | 327 | 287 (88) |  | 22 (7) |  | 18 (5) |  |
Occupation | Â | Â | 0.85 | Â | 0.24 | Â | 0.45 |
 With less forest exposure | 40 | 34 (85) |  | 2 (5) |  | 3 (7) |  |
 With more forest exposure | 1440 | 1208 (84) |  | 155 (11) |  | 70 (5) |  |
Past history of malaria | Â | Â | 0.53 | Â | 0.08 | Â | 0.02* |
 No | 644 | 536 (83) |  | 58 (9) |  | 45 (7) |  |
 Yes | 836 | 706 (84) |  | 99 (12) |  | 28 (3) |  |